Wednesday, April 4, 2012

Blood Mystery Solved: Two New Blood Types Identified

Two New Blood Types Identified

You probably know your blood type: A, B, AB or O. You may even know if you're Rhesus positive or negative. But how about the Langereis blood type? Or the Junior blood type? Positive or negative? Most people have never even heard of these.

Yet this knowledge could be "a matter of life and death," says University of Vermont biologist Bryan Ballif.
While blood transfusion problems due to Langereis and Junior blood types are rare worldwide, several ethnic populations are at risk, Ballif notes. "More than 50,000 Japanese are thought to be Junior negative and may encounter blood transfusion problems or mother-fetus incompatibility," he writes.
But the molecular basis of these two blood types has remained a mystery -- until now.
In the February issue of Nature Genetics, Ballif and his colleagues report on their discovery of two proteins on red blood cells responsible for these lesser-known blood types.
Ballif identified the two molecules as specialized transport proteins named ABCB6 and ABCG2.
"Only 30 proteins have previously been identified as responsible for a basic blood type," Ballif notes, "but the count now reaches 32."
The last new blood group proteins to be discovered were nearly a decade ago, Ballif says, "so it's pretty remarkable to have two identified this year."
Both of the newly identified proteins are also associated with anticancer drug resistance, so the findings may also have implications for improved treatment of breast and other cancers.
As part of the international effort, Ballif, assistant professor in the biology department, used a mass spectrometer at UVM funded by the Vermont Genetics Network. With this machine, he analyzed proteins purified by his longtime collaborator, Lionel Arnaud at the French National Institute for Blood Transfusion in Paris, France.
Ballif and Arnaud, in turn, relied on antibodies to Langereis and Junior blood antigens developed by Yoshihiko Tani at the Japanese Red Cross Osaka Blood Center and Toru Miyasaki at the Japanese Red Cross Hokkaido Blood Center.
After the protein identification in Vermont, the work returned to France. There Arnaud and his team conducted cellular and genetic tests confirming that these proteins were responsible for the Langereis and Junior blood types. "He was able to test the gene sequence," Ballif says, "and, sure enough, we found mutations in this particular gene for all the people in our sample who have these problems."

Transfusion Troubles
Beyond the ABO blood type and the Rhesus (Rh) blood type, the International Blood Transfusion Society recognizes twenty-eight additional blood types with names like Duffy, Kidd, Diego and Lutheran. But Langereis and Junior have not been on this list. Although the antigens for the Junior and Langereis (or Lan) blood types were identified decades ago in pregnant women having difficulties carrying babies with incompatible blood types, the genetic basis of these antigens has been unknown until now.
Therefore, "very few people learn if they are Langereis or Junior positive or negative," Ballif says.
"Transfusion support of individuals with an anti-Lan antibody is highly challenging," the research team wrote in Nature Genetics, "partly because of the scarcity of compatible blood donors but mainly because of the lack of reliable reagents for blood screening." And Junior-negative blood donors are extremely rare too. That may soon change.
With the findings from this new research, health care professionals will now be able to more rapidly and confidently screen for these novel blood group proteins, Ballif wrote in a recent news article. "This will leave them better prepared to have blood ready when blood transfusions or other tissue donations are required," he notes.
"Now that we know these proteins, it will become a routine test," he says.

A better match
This science may be especially important to organ transplant patients. "As we get better and better at transplants, we do everything we can to make a good match," Ballif says. But sometimes a tissue or organ transplant, that looked like a good match, doesn't work -- and the donated tissue is rejected, which can lead to many problems or death.
"We don't always know why there is rejection," Ballif says, "but it may have to do with these proteins."
The rejection of donated tissue or blood is caused by the way the immune system distinguishes self from not-self. "If our own blood cells don't have these proteins, they're not familiar to our immune system," Ballif says, so the new blood doesn't "look like self" to the complex cellular defenses of the immune system. "They'll develop antibodies against it," Ballif says, and try to kill off the perceived invaders. In short, the body starts to attack itself.
"Then you may be out of luck," says Ballif, who notes that in addition to certain Japanese populations, European Gypsies are also at higher risk for not carrying the Langereis and Junior blood type proteins.
"There are people in the United States who have these challenges too," he says, "but it's more rare."

Other Proteins
Ballif and his international colleagues are not done with their search. "We're following up on more unknown blood types," he says. "There are probably on the order of 10 to 15 more of these unknown blood type systems -- where we know there is a problem but we don't know what the protein is that is causing the problem."
Although these other blood systems are very rare, "if you're that one individual, and you need a transfusion," Ballif says, "there's nothing more important for you to know."

Saturday, March 3, 2012

Excellence and Relevance for Human Kind


Biotechnology - In Pursuit of Excellence and Relevance for Human Kind

The Department of Biotechnology is committed to generate excellence in biotechnology research for a strong, indigenous knowledge base and to ensure its application as a premier precision tool for creation of economic wealth for the welfare of the society and national prosperity. The last four decades represent the age of new Biology. Today biological sciences have become the harbinger of new and hitherto unimagined products and processes in the areas of food, feed, health, animal and plant productivity, environment conservation and energy generation. Sustainable development of our resources for ensuring food, nutritional, health, environmental and livelihood security of the people by harnessing the powers of biotechnology is a dream of the scientific community, being translated into products, processes and technologies. The focus during these two years has been on basic and application oriented new biology and biotechnology covering agriculture and plants, genomics, molecular medicine, bioinstrumentation, bioinformatics, biofuels, biofertilizers, biopesticides, human resource development and environment and biodiversity. The Department has developed biosafety protocols and guidelines related to ethical issues. Partnership with the industry for commercialization of technology and marketing of bioproducts is another area where there has been some success. A major pursuit thus has been to bring synergy between researchers, academicians, industry, policy makers and public.

Vision - Biotechnology -A Ten Year Perspective
On September 7, 2001, Hon'ble Prime Minister, Shri Atal Bihari Vajpayee released the 'Biotechnology - A Vision - Ten Year Perspective' document of the department. The expert advice from a large number of scientists from India and abroad has been obtained in its preparation. The goals outlined in the vision document are achievable within ten years for a biotechnology based, environmentally sound, sustainable societal development and a bioindustrial revolution through excellence in bioscience innovations, discoveries and increased understanding of life processes.  Our vision is 'Attaining new heights in biotechnology research, shaping biotechnology into a premier precision tool of the future for creation of wealth and ensuring social justice – specially for the welfare of the poor'. Areas where significant progress has been made with important achievements are briefly touched upon as below :

Crop Biotechnology : Successful transgenic research has been carried out on banana, cabbage, mustard, mungbean, and wheat for crop improvement, increased nutritional value, disease resistance, and better shelf life, particularly in cotton and rice. Transgenic system of indica rice and wheat have been developed; rice transformed with 3 genes and wheat with one gene to confer stress resistance. A nutritionally important gene AmA1 isolated from Amaranthus has been successfully transferred to Potato. India is now a partner in the International Rice Genome Programme with the responsibility to sequence a part of Chromosome 11. Bt. Cotton trials at several locations have been monitored. The data indicates that Bt. Cotton has an average yield advantage of around 4.0 times over non-Bt. Cotton. No effects of Bt. Protein have been noticed on non-target and beneficial insects.

Plant Tissue Culture : Protocol standardization has been completed for a number of species of forest trees, horticulture and plantation crops. Different crosses have been developed in a variety of orchids. Field demonstration trials are being conducted for tissue culture raised coffee, pepper and tea. Complete regeneration systems are now available for 20 different species. Transformation system has been developed forPopulus species. A Polymerase Chain Reaction (PCR) based molecular diagnostic kit has been perfected for the detection of Banana Bunchy Top virus. The Micropropagation Technology Parks at TERI, New Delhi and NCL, Pune have produced 10 million plantlets field planted over an area of 6500 ha at various locations in 17 States.

Medicinal and Aromatic Plants : A network of four Gene Banks has been set up for ex - situ conservation of rare, endangered and commercially important medicinal and aromatic plants. About 27,000 stem cuttings of Taxus have been raised and 1500 plants established in natural habitat. Agrotechnology package has been developed for a new variety of Artemisia annua containing 0.5 - 1.3% artemisinin and yielding up to 80 kg of artemisinin / ha. An isoquinoline alkaloid, berberin, which acts as an immunomodulatory agent has been identified and isolated from Berbris aristata (Berberry). A herbal product is being developed for burn cases. In vitro bioscreens have been developed for assaying the anti-proliferative and anti - diabetic medicinal plants. A Mission progamme has been initiated for the development of herbal products with the help of biotechnology tools.

Bioprospecting and Molecular Taxonomy : Biome maps for North-Eastern and Western Himalayas have been prepared. Taxus and its associated species have been mapped in Talle Valley of Arunachal Pradesh. A Biomonitoring System has been evolved. The documentation and characterization of ten identified species of the two hot spots has been completed. Molecular characterization of identified economically important species is being carried out. A cold related gene has been identified from a plant species in Spiti region of Himachal Pradesh. 23 salt tolerant gene have been isolated and cloned from the Mangrove region in Western Ghats. Anti-pesticidal fractions have been identified from a tree species for resistance against Cotton Boll worm; 88% growth inhibition recorded. Agriculturally important bioactive compounds have also been identified from five species of the Kumaon and Garhwal Region.

National Bioresource Development Board : Under the National Bioresource Development Board inventorisation, characterization and sustainable development of the bioresources of various agro-climatic zones and fragile ecosystems of the country has been undertaken.

Animal Biotechnology : Transgenic mice expressing neomycin resistance gene, green fluorescent protein gene and other genes have been produced. A buffalo chromosome probe for sex determination of embryo is being applied in the field. Rabies vaccine for animals using vero cell culture is being validated before commercialisation. Conjugates are being evaluated in female dogs for the efficacy of recombinant dog zona pellucida glycoprotein to regulate fertility.

Aquaculture and Marine Biotechnology : A PCR based diagnostic method for white spot syndrome virus of shrimp and vaccines for fish pathogens against infection ofAeromonas sp. and Pseudomonas sp. have been developed. A process has been perfected for the preparation of pathogen free fermented silkworm pupae silage to act as an ingredient in the animal feed. A feed unit with a capacity of 250 kg pellets per hour has been established at Central Institute of Freshwater Aquaculture. Some bioactive compounds from marine organisms are under development.

Medical Biotechnology : A therapeutic immunomodulator for Leprosy is now available as ‘Leprovac’ in the market. Genetically modified live cholera vaccine has completed Phase-I clinical trials in humans with no side effects. The anti-fertility vaccine to control fertility in women has been found to produce specific antibodies at a desired level. Steps are being taken for pilot scale production of Rotaviral candidate vaccines for Phase-I clinical trials in the country. For Japanese Encephalitis, efforts are on to produce the candidate vaccine to serve as a replacement for the mouse brain derived JE vaccine. A DNA sequence has been identified for its potential use as a vaccine for Rabies. A recombinant BCG carrying a gene for Microbium tuberculosis has been developed. The recombinant proteins and peptide based candidate vaccines are awaiting clinical testing for malaria. Fourteen diagnostic technologies like IgM, Mac ELISA assay systems for detection of Dengue, Japanese Encephalitis & West Nile; ELISA system to measure alpha-fetoprotein levels in women; IgM based test system for detection of Hepatitis- ‘A’ virus and urine based ELISA systems for detection of four reproductive hormones have been validated. Two diagnostic test systems developed for HIV have been transferred to industry. Goat hepatocytes were found at Deccan Medical College, Hyderabad to be more compatible as compared to porcine hepatocytes for transplantation in patients with acute fulminate hepatic failures in humans.

Human Genetics and Genome Analysis : Novel mutations in gene responsible for retinoblastoma at L.V. Prasad Eye Institute, Hyderbad provide help in screening and counseling of patients and their affected families. A multiplex Polymerase Chain Reaction (PCR) is being used to provide diagnosis and counseling in Spinocerebellar ataxias. Sixteen genetic diagnosis cum counseling units have been set up in the country for prenatal diagnosis and counseling for major genetic disorders. Almost fourteen thousand affected families have benefited from this programme. Around 2000 tribals have been screened for detecting various genetic disorders. A National Bioethics Committee has formulated ethical policies for research on human genetics and genomics.

Microbial and Industrial : Several microbial strains have been isolated for leaching of metal ores of Copper, Zinc and Gold. Microbial polysaccharide gellan and xanthan have been produced in high concentration using Sphingomonas sp. Production of cyclodextrin has been standardised using microbial strains of Bacillus firmes and Klebsiella pneumoniae. Technology for the bioremediation of Manganese and Zinc mine dumps has been developed through integrated biotechnological approach. Technologies for the production of xylanase, inulinase, lipase and protease have been developed. Patents on cephalosporin process and rifimycin-shuttle vectors have been obtained in India and USA. For xanthan gum, an indigenous production process as an import substitute developed at Birla Institute of Scientific Research, Jaipur has been transferred to Sriram Biotech Ltd., Hyderabad. A programme on microbial biodiversity for accession of important microorganisms has been initiated.

Biological Pest Control : Technologies for the mass production of candidate biocontrol agents, baculovirus, parasites, predators, antagonists, fungi and bacteria for economically important crops have been transferred to industry. The important crops include coffee, cotton, oilseeds, pulse, spices, sugarcane, tea and vegetables. A crop area of 65,000 ha has been covered under biocontrol / biopesticide efficacy demonstration. Use of twelve candidate biopesticides has been successfully demonstrated in different agro-climatic zones. Baculovirus based technology has been developed for management of forest insect pest (teak defoliator). Integrated Pest Management module has been developed for green (organic) cotton under irrigated conditions. Fermentation based technologies of three fungal biocontrol agents have been transferred to industry. New potential biopesticide technologies are being revalidated for commercialization.

Biofertilisers : Mass production technologies for Azotobacter, Azospirillum, Blue Green Algae (BGA), Mycorrhiza and Rhizobium have been developed and transferred to industry for production and marketing. It has been found that Rhizobium biofertiliser can save upto 25-30 kg chemical nitrogen in pulses and leguminous oil seeds. Azotobacter, Azospirillum and Mycorrhiza can make phosphate available in soluble form with other micronutrients to most of the commercial crops. Around 10,000 demonstration programmes benefiting about 35000 farmers have been conducted.

Biodiversity Conservation and Environment : Technology package for eco-restoration of mine spoil dumps and phytoremediation of dye industry effluent has been standardized. An efficient crude oil and oil sludge degrading bacterial consortium 'Oil Zapper' and biobeneficiation and desulphurisation technologies have been transferred to the industry.

Seribiotechnology : A programme on silkworm genome has been initiated at the Centre for DNA Fingerprinting and Diagnostics, Hyderabad. A technique has been standardised for effective degumming of silk using fungal protease enzyme for better lusture and softness of dupion silk. Field trials of immunodiagnostic kits have been conducted at farmers' level for early detection of infectious flatcherie disease. More than 100 microsatellite DNA markers have been identified to be used for mapping genes of silkworm. Eight molecular RFLP markers linked to the cocoon shell character of the silkworm have been identified. They are likely to be used in directional breeding programme. Expression of marker genes has been demonstrated in silkworm. Silkworm is likely to be used as a bioreactor in future. Gynogenic haploids have been produced in mulberry and are being field evaluated.

Food Biotechnology : Low cost nutritious food supplements for school going children have been developed. Large-scale production of Betalains (food colorant) and Oyster mushroom optimized. Process for preparation of clarified fruit juices with aroma retention and food flavours developed. Diagnostic kits for rapid detection of food borne pathogens have been developed.

Repositories and Biotech Facilities : A large number of infrastructure facilities and repositories have been set up in different universities and research institutes to facilitate advance research. The facility at IMTECH, Chandigarh for the microbial type culture collection has now been upgraded to an International Depository Authority (IDA). The repository on Drosophila has been strengthened to develop educational kits for demonstrating genetic experiments in schools and colleges. Studies at the repository on filaria have resulted in patenting of a unique filarial antigen. Genetic engineering and strain manipulation has demonstrated over production of daunorubicin and anti-cancer antibiotic at pilot scale. A national containment facility has been set up at NBPGR, New Delhi to look into various quarantine issues relating to transgenic planting materials. A National Facility for Virus Diagnosis and Quality Control in Tissue Culture raised Planting Materials has been set up at Indian Agricultural Research Institute, New Delhi with six satellite centres. This facility will certify all domestic and export consignments.

Bioinformatics : India is one of the first countries in the world to initiate a Bioinformatics programme. A National Bioinformatics Network has been evolved for sustainable utilization of the biological data resources. The 56 centres, six interactive computer graphics facilities and four post graduate diploma courses in Bioinformatics are being supported. Internationally recognized databases such as EMBnet, PDB, GDB, EBI and Plant Genome database have been established in the form of Mirror sites under the National Jai Vigyan S&T mission. These databases are being utilized for genomic and proteomic R&D activities through high speed and high bandwidth network services.

Human Resource Development : With sixty two biotechnology teaching programmes in various Indian universities and institutions about 1600 students have been trained in two years. These include a special programme in Neurosciences. National and Overseas Associateships awarded annually to about 45 scientists has resulted in very good expertise. National Bioscience Awards for Career Development and National Women Bioscience Awards are conferred annually to recognize the outstanding contributions of biotechnologists in various fields. Number of biotechnology scholarships given to school leaving students to encourage them to pursue a career in biology related areas has been raised from 10 to 25 per year.

IPR and Biosafety : A Biotechnology Patent Facilitating Cell has filed 75 patents. Roving seminars are conducted at regular intervals to create awareness on Intellectual Property Rights and related issues.

Biotechnology for Societal Development : Training, large scale demonstration and cooperative marketing activities in the areas of food processing, leafy vegetable and mushroom cultivation, vermicomposting, organic farming, orchids, ornamental plants, conservation of rare and endangered herbal medicinal plant species have benefited this target group significantly. Sericulture has been introduced in non-traditional areas for economic upliftment of women. A Women’s Biotechnology Park with many industrial modules at Chennai is a success. Biotechnological interventions for disaster management have given rich dividends.

Biovillage : A Biovillage at Mocha village, Porbandar for extension of technologies which are pro-poor, pro-women and pro-nature to the grass root level has been a model for rural development. Farmers of target village have been trained in production and use of bio-fertilizers, bio-pesticides, modern farming practices and cultivation of marine algae seaweeds. Cultivation of medicinal and economically important plant species has been undertaken in the wasteland of the village. A desalination unit for pure water has also been set up.

Autonomous Institutions : The Department has set up following autonomous institutions for achieving excellence in specialized areas which have been further strengthened :
  1. National Centre for Plant Genome Research, New Delhi
  2. National Brain Research Centre, Gurgaon.
These institutes are working in the frontier areas of New Biology and Biotechnology, have a high degree of excellent publications to their credit and many research leads have been converted into products and processes and transferred to industry. Recently the institute for Bioresources and Sustainable Development has been established at Imphal under the auspices of the National Bioresource Development Board.

Biotechnology in Different States : The dialogue is on with various States for developing initiatives in biotechnology, specially to deal with location specific problems.

Jai Vigyan National Science & Technology Missions : Four mission projects implemented by DBT have made significant progress. These are: Generation of new vaccines; herbal product development, coffee improvement and establishment of mirror sites.

International Collaboration : Under the Integrated Long Term Programme of Indo-Russian collaboration in biotechnology an Indo-Russian Centre for Biotechnology is being established. A new phase of Indo-Swiss collaboration in biotechnology is under implementation during 1999-2004 with focus on biotechnology applications in agriculture and environment with special reference to improvement of wheat and pulses. Vaccine and contraception, brain research and genomics are the areas for joint programmes with USA. More than a dozen new collaborations both with developing and developed countries have been initiated. Thus, biotechnology research and application are moving in a new direction for creation of a strong knowledge base and for conversion of this knowledge into economic and societal benefit.

Monday, February 27, 2012

Bt-Crops


Biosafety of Bt-Crops Safe Transition
Introduction
Insect pest management in agriculture is important to safeguard crop yields and productivity. A large number of chemical insecticides that effectively control insect pests have been proven to be harmful to human health and environment. There is a need to reduce the dependence on pesticides by using safer alternatives to manage insect pests. Many insecticidal proteins and molecules are available in nature, which are effective against agriculturally important pests but innocuous to mammals, beneficial insects and other organisms. Insecticidal proteins present in the soil borne bacterium, Bacillus thuringiensis (Bt), which has demonstrated its efficacy as a spray formulation in agriculture over the past five decades, have been
expressed in many crop species with positive results (Kumar et al., 1996). Bt-transgenic crop species (cotton, corn, rice, tomato and potato) have been commercialized with substantial benefits to the farmers (Kumar 2003). Bt crops were cultivated in an area of 32.1 million hectares out of the global transgenic area of 102.0 million hectares in 2006 (James 2006).
Bacillus thuringiensis
Bt is a gram-positive, aerobic, endospore-forming bacterium belonging to morphological group I along with Bacillus cereus, Bacillus anthracis and Bacillus laterosporus. All these bacteria have endospores. Bt, however, is recognized by its parasporal body (known as the crystal) that is proteinaceous in nature (see figure above) and which possesses insecticidal properties. The parasporal body comprises of crystals varying in size, shape and morphology. The crystals are tightly packed with proteins called protoxins or-endotoxins.
There are many subspecies and serotypes of Bt with a range of well-characterized insecticidal proteins or Bt toxins (-endotoxins). At present it has been estimated that over 60,000 isolates of Bt are being maintained in culture collections worldwide. Known Bt toxins kill subsets of insects among the Lepidoptera, Coleoptera, Diptera and nematodes. The host range of Bt has expanded considerably in recent years due to extensive screening programs. Currently more than 140 different genes encoding Bt toxins have been cloned.
Mode of action
The Bt toxins exert their toxicity by forming pores in the larval midgut epithelial membranes. Initially the protoxins are activated in the midgut by trypsin-like proteases to toxins (see figure below). The active toxins bind to specific receptors located on the apical brush border membrane of the columnar cells. Binding is followed by insertion of the toxin into the apical membrane leading to pore formation (see figure below). The formation of toxin-induced pores in the columnar cell apical membrane allows rapid fluxes of ions. Different studies revealed that the pores are K+ selective, permeable to cations, anions or permeable to small solutes like sucrose,
irrespective of the charge. It appears that the toxin forms or activates a relatively large aqueous channel in the membrane. The disruption of gut integrity results in the death of the insect from starvation or septicemia.
Applications of Bt
The first practical application of Bt dates back to 1938 when it was sold as 'Sporeine' in France for the control of European corn borer. The growing realization that organic insecticides are deleterious to the environment and human health spurred a renewed interest in Bt in the 1960s, which led to the introduction of viable Bt biopesticides like Thuricide and Dipel. Bt is the most popular biological control agent with worldwide sales of about $100 million. Bt spray formulations comprise 5% of total global pesticide market. The use of conventional Bt biopesticides, however, was found to have limitations like narrow specificity, short shelf life, low potency, lack of systemic activity, and the presence of viable spores.

An elegant and most effective delivery system for Bt toxins is the transgenic plant. The major benefits of this system are economic, environmental, and qualitative. In addition to the reduced input cost to
the farmer, the transgenic plants provide season-long protection independent of weather conditions, effective control of burrowing insects difficult to reach with sprays and control at all of the stages of insect development. The important feature of such a system is that only insects infesting the crop are exposed to the toxin.
Introduction and expression of Bt genes in crop plants conferred significant protection against target pests. The first transgenic Bt-crops viz., cotton, corn and potato were commercialized in USA in 1995 and 1996. Currently more than a dozen countries cultivate Bt-crops. Bt-cotton was permitted for commercial cultivation in India in 2002.
Biosafety
Safety of Bt toxins in terms of toxicity and allergenicity towards mammals and other non-target organisms is well documented (Glare and O'Callaghan, 2000). The salient features are:
Lack of receptors that bind to Bt toxins and instant degradation of Bt toxins in human digestive system make them innocuous to human beings.
Community exposure to Bt toxins/spray formulations over a period of six decades has not resulted in any adverse effects.
Lack of homology to any allergenic protein/epitope sequences makes Bt toxins non-allergenic.
Consumption of foods derived from Bt corn, potato, tomato and rice over the past one decade has not led to any adverse effects in the populations. Consumption of foods derived from Bt corn, potato, tomato and rice over the past one decade has not led to any adverse effects in the populations.
Federation of Animal Societies of USA (2001) observed that Bt crop products (corn) fed to chicken-broilers, chicken-layers, catfish, swine, sheep, lactating dairy cattle and beef cattle did not show any adverse effects on growth, performance, observed health of the animals and composition of meal, milk, eggs, etc.,
Dairy cows fed with corn and Bt-corn did not exhibit any significant differences in lactation and ruminal fermentation
Bt, Bt-sprays, Bt-crops and Bt-crop products are safe to non-target organisms such as soil microorganisms (protozoa and fungi) collembola, molluscs, crustaceans, spiders, aquatic insects, predators, parasitoids, arthropods, honey bees, lady bird beetles, earthworms, salamanders, bird species, small and large mammals, etc.
Benefits of Bt-crops
The International Service for the Acquisition of Agri-biotech Applications (ISAAA) conducted a detailed survey of the Bt-cotton cultivation, adoption and performance in eight countries (USA, Australia, China, India, Mexico, Argentina, South Africa and Indonesia) in 2002 (James, 2002). All the countries that have introduced Bt cotton have derived significant and multiple benefits. These include increases in yield, decreased production costs, a reduction of at least 50% in insecticide applications resulting in substantial environmental and health benefits to small producers, and significant economic and social benefits. In a recent study at Indian Institute of Management (Ahmedabad), Gandhi and Namboodiri (2006) observed that cotton farmers in major cotton-growing states such as Gujarat, Maharashtra, Andhra Pradesh and Tamil Nadu were benefited significantly. On a global basis, the benefits from the deployment of Bt cotton between 1998 and 2001 were estimated to be $1.7 billion. Surveys conducted among small resource-poor farmers in developing countries, mainly in China and South Africa, revealed that Bt cotton contributed to reduction in poverty by increasing incomes of small farmers.
The environmental benefits of cultivating pest-resistant transgenic crops are more profound and invisible. These are enumerated below:
Reduction in use of pesticides: The estimated total savings of insecticides on Bt cotton in 2001 was of the order of 10,627 MT, which is equivalent to 13% of the 81,200 MT of all insecticides used on cotton globally in 2001.
Fewer insecticides in aquifers and the environment: The substantial decrease in insecticides associated with the cultivation of Bt cotton has led to significant decrease in insecticide run off into watersheds, aquifers, soils and generally into the environment. More widespread global cultivation of Bt-cotton will further improve the water quality.
Reduced farmer exposure to insecticides and improvement of human health: Substitution of the chemical insecticides with Bt cotton has clearly reduced the risks to farm workers and to others in the farm community who may be exposed to the former’s toxicity. These effects are particularly important in developing countries where modern application techniques are neither always adopted nor available for use.
Increased populations of beneficial insects: The global use of broad spectrum insecticides on cotton has adversely affected and decreased the populations of non-target species including the arthropod natural enemies that can provide effective control of non-lepidopteran pests. Various studies confirmed that the arthropod natural enemy populations in Bt cotton are greater than in non-Bt cotton. In addition to reducing the number of sprays for the bollworm/budworm complex, Bt cotton has also reduced the number of sprays for other insects such as thrips and aphids. This effect has been attributed to higher populations of beneficial predators and parasitic insects that are eliminated by insecticide sprays.
Reduced risk for wildlife: Reduction in the use of insecticides, many of which are highly toxic to wildlife will reduce the risks to mammals, birds, bees, fish and other organisms. Many birds are dependent on insects for food and their elimination through the use of insecticides deprives birds of their food source.
Reduced fuel and raw material consumption and decreased pollution: Lowering the demand for insecticides through the use of Bt cotton reduces tractor fuel usage as a result of reduction in number of sprays, which in turn reduces air pollution. For example, in the Hebei Province of China, where adoption of Bt cotton increased dramatically from its introduction in 1997 to 97% in 2001, farmers have noticed a substantial improvement from the chronic air, soil and water pollution levels prior to the introduction of Bt cotton in 1997, caused by the intensive spraying of cotton with insecticides.
The ecological benefits of cultivating Bt-crops were recently documented in a comprehensive manner by Sanvido et al. (2006). According to this study cultivation of Bt corn and Bt cotton resulted in significant environmental benefits. In conclusion, Bt crops are safe and beneficial to farmers, human society, non-target organisms, biodiversity and environment in general.
References
Dale, P. J., Clarke, B. and Fontes, E. M. G. 2002. Potential for the environmental impact of transgenic crops. Nature Biotechnology. 20: 567-574.
Gandhi, V. P. and Namboodiri, N. V. 2006. The adoption and economics of Bt-cotton in India. W.P. No. 2006-09-04, IIM, Ahmedabad
Glare, T. R. and O'Callaghan, M. 2000. Bacillus thuringiensis: Biology, Ecology and Safety. John Wiley, Chichester.
James, C. 2002. Global review of commercialized transgenic crops: 2001. Feature: Bt-cotton. ISAAA Brief No. 26, ISAAA, Ithaca.
James, C. 2006. Global status of commercialized Biotech/GM crops. ISAAA Brief No. 35, ISAAA, Ithaca.
Kumar, P. A., Sharma, R. P. and Malik,. V. S. 1996. Insecticidal proteins of Bacillus thuringiensis. Advances in Applied Microbiology. 42:1-43.
Kumar, P. A. 2003. Insect pest-resistant transgenic crops. In: Advances in Microbial Control of Insect Pests, Upadhyay, R. K. Ed. pp. 71-82. Kluwer Academic, New York.
Sanvido O, Stark M, Romeis J and Bigler F, 2006. Ecological benefits of genetically modified crops. Swiss Expert Committee on Biosafety, Federal Department of Economic Affairs, Switzerland.